Lyfstone AS is a medical technology manufacturer based in Tromsø. The company has developed a Calprotectin POC test that is specialized for the early detection of periprosthetic joint infection (PJI). The test uses synovial fluid as the sample material, which provides a fast and efficient diagnosis of infections that can occur after joint surgery.
The results from the test are available in just 15 minutes, which represents a significant time saving compared to traditional methods. The clinically proven performance allows the test to contribute to a more cost-effective solution in healthcare. Lyfstone AS focuses on improving the quality of life for patients by offering a new method for diagnosing PJI, which can lead to faster treatment and better outcomes for those affected.